7Baggers
 Aptevo Therapeutics : 13 November 2025 Investor Presentation  MarketScreener Thu, 13 Nov 2025 12:51:08 GMT
 aptevo presents preclinical data for new trispecific cancer antibody  Investing.com Mon, 10 Nov 2025 13:16:09 GMT
 aptevo therapeutics sees cash runway into 4q26  TipRanks Fri, 07 Nov 2025 02:12:24 GMT
 aptevo bets big on new cancer drugs despite widening losses  Finimize Thu, 06 Nov 2025 21:33:14 GMT
 apvo: roth capital hosts virtual meeting in november  GuruFocus Thu, 06 Nov 2025 19:04:13 GMT
 aptevo (apvo) advances in clinical programs with promising aml t  GuruFocus Thu, 06 Nov 2025 14:42:31 GMT
 Aptevo Therapeutics Reports 3Q25 Financial Results And Provides A Business Update  standard-journal.com Thu, 06 Nov 2025 13:06:13 GMT
 Aptevo Therapeutics sees cash runway into 4Q26  TipRanks Thu, 06 Nov 2025 08:00:00 GMT

Aptevo Therapeutics Inc
(NASDAQ:APVO) 

APVO stock logo

Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1/1b clinic...

Founded: 2016
Full Time Employees: 80
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends